Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gibb

Showing results (201-210 of 419) with videos related to

Pageof 42
Sort By:
BMC Public Health|August 29, 2019
Self-harm in young people with perinatal HIV and HIV negative young people in England: cross sectional analysisJulie Copelyn, Lindsay C Thompson, Marthe Le Prevost, et al.
Tropical Medicine & International Health : TM & IH|December 24, 2010
A primary care level algorithm for identifying HIV-infected adolescents in populations at high risk through mother-to-child transmissionRashida A Ferrand, Helen A Weiss, Kusum Nathoo, et al.
Antiviral Therapy|April 30, 2016
Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected childrenAdeodata Kekitiinwa, Victor Musiime, Margaret J Thomason, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 11, 2008
Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and ZimbabweSylvia K Muyingo, A Sarah Walker, Andy Reid, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 2, 2016
Cognitive Function in Young Persons With and Without Perinatal HIV in the AALPHI Cohort in England: Role of Non-HIV-Related FactorsAli Judd, Marthe Le Prevost, Diane Melvin, et al.
American Journal of Public Health|October 25, 2011
Perception of risk of vertically acquired HIV infection and acceptability of provider-initiated testing and counseling among adolescents in ZimbabweRashida A Ferrand, Caroline Trigg, Tsitsi Bandason, et al.
AIDS (London, England)|January 7, 2017
Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tabletsAndrzej Bienczak, Paolo Denti, Adrian Cook, et al.
AIDS (London, England)|April 19, 2013
Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?Quirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2016
Plasma Efavirenz Exposure, Sex, and Age Predict Virological Response in HIV-Infected African ChildrenAndrzej Bienczak, Paolo Denti, Adrian Cook, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 22, 2008
Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/IrelandAddy Kekitiinwa, Katherine J Lee, A Sarah Walker, et al.
Pageof 42

Showing results (201-210 of 419) with videos related to

Sort By:
Pageof 42
BMC Public Health|August 29, 2019
Self-harm in young people with perinatal HIV and HIV negative young people in England: cross sectional analysisJulie Copelyn, Lindsay C Thompson, Marthe Le Prevost, et al.
Tropical Medicine & International Health : TM & IH|December 24, 2010
A primary care level algorithm for identifying HIV-infected adolescents in populations at high risk through mother-to-child transmissionRashida A Ferrand, Helen A Weiss, Kusum Nathoo, et al.
Antiviral Therapy|April 30, 2016
Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected childrenAdeodata Kekitiinwa, Victor Musiime, Margaret J Thomason, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 11, 2008
Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and ZimbabweSylvia K Muyingo, A Sarah Walker, Andy Reid, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 2, 2016
Cognitive Function in Young Persons With and Without Perinatal HIV in the AALPHI Cohort in England: Role of Non-HIV-Related FactorsAli Judd, Marthe Le Prevost, Diane Melvin, et al.
American Journal of Public Health|October 25, 2011
Perception of risk of vertically acquired HIV infection and acceptability of provider-initiated testing and counseling among adolescents in ZimbabweRashida A Ferrand, Caroline Trigg, Tsitsi Bandason, et al.
AIDS (London, England)|January 7, 2017
Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tabletsAndrzej Bienczak, Paolo Denti, Adrian Cook, et al.
AIDS (London, England)|April 19, 2013
Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?Quirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2016
Plasma Efavirenz Exposure, Sex, and Age Predict Virological Response in HIV-Infected African ChildrenAndrzej Bienczak, Paolo Denti, Adrian Cook, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 22, 2008
Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/IrelandAddy Kekitiinwa, Katherine J Lee, A Sarah Walker, et al.
Pageof 42